{"id":6932,"date":"2017-09-08T09:08:26","date_gmt":"2017-09-08T13:08:26","guid":{"rendered":"https:\/\/themedicalxchange.com\/?p=6932\/"},"modified":"2022-11-17T10:22:18","modified_gmt":"2022-11-17T15:22:18","slug":"cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease","status":"publish","type":"post","link":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/","title":{"rendered":"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease"},"content":{"rendered":"<h2>Anti-inflammatory Therapy for CV Protection<\/h2>\n<p>\u201cThese findings represent the end game of more than two decades of research, stemming from a critical observation that half of heart attacks occur in people who do not have high cholesterol,\u201d said CANTOS principal investigator Dr. Paul M. Ridker, Director, Center for Cardiovascular Disease Prevention, Brigham and Women\u2019s Hospital, Boston, Massachusetts. The CANTOS data were presented as a latebreaker at this year\u2019s ESC and simultaneously published in the <em>New England Journal of Medicine<\/em> (Ridker PM et al. <em>N Engl J Med<\/em> 2017; Aug 17 epub ahead of print).<\/p>\n<p>\u00a0In CANTOS, 10,061 patients with a previous MI and a high-sensitivity C-reactive protein (hs-CRP) of \u2265 2 mg\/L were randomized to one of three doses of the monoclonal antibody canakinumab or placebo. All therapies were administered subcutaneously every three months. Canakinumab, which is approved in many countries for the treatment of rheumatologic disorders, targets IL-1\u03b2, a cytokine considered central to inflammation. At entry, 97% of patients were on statins and the median LDL-C was approximately 2.0 mmol\/L.<\/p>\n<p>\u00a0At a median follow-up of 3.7 years, the hazard ratio (HR) for the composite primary efficacy endpoint of nonfatal MI, nonfatal stroke, or CV death met the prespecified multiplicity-adjusted threshold for statistical significance for canakinumab 150 mg relative to placebo (HR 0.85; <em>P<\/em>=0.021) \u00a0<a href=\"javascript:void(0)\" class=\"show-image\" data-index=\"0\">(Fig. 1)<\/a>. This 15% reduction in events was similar to that achieved with the highest dose of 300 mg (HR 0.86; <em>P<\/em>=0.031). The relative 7% reduction in events for the lowest dose (50 mg) did not reach statistical significance (<em>P<\/em>=0.3). For the 150 mg dose, there was also a significant 17% reduction in a secondary composite endpoint that included hospitalization for unstable angina leading to revascularization (<em>P<\/em>=0.005). At 48 months, there were significant reductions in hs-CRP for canakinumab relative to placebo in a dose relationship, reaching 41% for the highest dose.<\/p>\n<p>\u00a0As has been observed with other agents targeted at inflammatory cytokines, canakinumab was associated with a higher incidence of infections than placebo, including fatal infections (0.31 vs. 0.18; <em>P<\/em>=0.02). However, canakinumab was associated with a lower incidence of fatal cancers (0.45 vs. 0.64; <em>P<\/em>=0.02) in a dose-dependent manner. The agent was also associated with significantly lower rates of arthritis, gout, and osteoarthritis. There was no significant difference between canakinumab and placebo for all-cause mortality.<\/p>\n<p>\u00a0The results of CANTOS establish a new chapter in preventive cardiology, according to Dr. Ridker. He characterized the protection from CV events associated with diet and exercise as the first era and the protection from cholesterol lowering as the second era. The data from CANTOS, associating anti-inflammatory therapy with CV protection, \u201cis cracking the door open on the third era.\u201d<\/p>\n<h2>Conclusion<\/h2>\n<p>In a <em>New England Journal<\/em> <em>of Medicine <\/em>accompanying editorial, Dr. Robert Harrington, Chairman, Department of Medicine, Stanford University, California, largely agreed. He wrote, \u201cCANTOS has helped move the inflammatory hypothesis of coronary artery disease forward.\u201d He remains circumspect about the routine use of canakinumab or other anti-inflammatory agents until more is known about efficacy, safety, and cost, but he conceded that these data have created \u201cscientific and clinical excitement\u201d about the potential of \u201ca new mechanism of action to attack.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p><b> Barcelona <\/b> &#8211; In patients with a previous myocardial infarction (MI), a therapy targeted at an inflammatory cytokine has been associated with a significant reduction in major cardiovascular (CV) events. This clinical benefit, demonstrated in the placebo-controlled multinational CANTOS trial, which randomized more than 10,000 patients, confirms that inflammation is an important driver of coronary artery disease, a result that alters fundamental conceptions of disease pathology and establishes a new option for treatment.<\/p>\n","protected":false},"author":9,"featured_media":6955,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"tags":[405,296,372,481],"class_list":["post-6932","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-405","tag-cardiology","tag-esc","tag-extract","area_tag-cardiology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease - The Medical Xchange<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease - The Medical Xchange\" \/>\n<meta property=\"og:description\" content=\"Barcelona - In patients with a previous myocardial infarction (MI), a therapy targeted at an inflammatory cytokine has been associated with a significant reduction in major cardiovascular (CV) events. This clinical benefit, demonstrated in the placebo-controlled multinational CANTOS trial, which randomized more than 10,000 patients, confirms that inflammation is an important driver of coronary artery disease, a result that alters fundamental conceptions of disease pathology and establishes a new option for treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"The Medical Xchange\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-08T13:08:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-17T15:22:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/09\/EX-7014_ESC_EN_Fig_1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Daniela Lopes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniela Lopes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/\"},\"author\":{\"name\":\"Daniela Lopes\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/f3318b53ccceaeb046bcb26e99f5c94c\"},\"headline\":\"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease\",\"datePublished\":\"2017-09-08T13:08:26+00:00\",\"dateModified\":\"2022-11-17T15:22:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/\"},\"wordCount\":512,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2017\\\/09\\\/EX-7014_ESC_EN_Fig_1.png\",\"keywords\":[\"2017\",\"cardiology\",\"ESC\",\"extract\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/\",\"name\":\"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease - The Medical Xchange\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2017\\\/09\\\/EX-7014_ESC_EN_Fig_1.png\",\"datePublished\":\"2017-09-08T13:08:26+00:00\",\"dateModified\":\"2022-11-17T15:22:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/f3318b53ccceaeb046bcb26e99f5c94c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2017\\\/09\\\/EX-7014_ESC_EN_Fig_1.png\",\"contentUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2017\\\/09\\\/EX-7014_ESC_EN_Fig_1.png\",\"width\":960,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/09\\\/08\\\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\",\"name\":\"The Medical Xchange\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/f3318b53ccceaeb046bcb26e99f5c94c\",\"name\":\"Daniela Lopes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g\",\"caption\":\"Daniela Lopes\"},\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/author\\\/daniela\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease - The Medical Xchange","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/","og_locale":"en_US","og_type":"article","og_title":"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease - The Medical Xchange","og_description":"Barcelona - In patients with a previous myocardial infarction (MI), a therapy targeted at an inflammatory cytokine has been associated with a significant reduction in major cardiovascular (CV) events. This clinical benefit, demonstrated in the placebo-controlled multinational CANTOS trial, which randomized more than 10,000 patients, confirms that inflammation is an important driver of coronary artery disease, a result that alters fundamental conceptions of disease pathology and establishes a new option for treatment.","og_url":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/","og_site_name":"The Medical Xchange","article_published_time":"2017-09-08T13:08:26+00:00","article_modified_time":"2022-11-17T15:22:18+00:00","og_image":[{"width":960,"height":720,"url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/09\/EX-7014_ESC_EN_Fig_1.png","type":"image\/png"}],"author":"Daniela Lopes","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Daniela Lopes","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/#article","isPartOf":{"@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/"},"author":{"name":"Daniela Lopes","@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/f3318b53ccceaeb046bcb26e99f5c94c"},"headline":"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease","datePublished":"2017-09-08T13:08:26+00:00","dateModified":"2022-11-17T15:22:18+00:00","mainEntityOfPage":{"@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/"},"wordCount":512,"commentCount":0,"image":{"@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/09\/EX-7014_ESC_EN_Fig_1.png","keywords":["2017","cardiology","ESC","extract"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/","url":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/","name":"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease - The Medical Xchange","isPartOf":{"@id":"https:\/\/themedicalxchange.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/#primaryimage"},"image":{"@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/09\/EX-7014_ESC_EN_Fig_1.png","datePublished":"2017-09-08T13:08:26+00:00","dateModified":"2022-11-17T15:22:18+00:00","author":{"@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/f3318b53ccceaeb046bcb26e99f5c94c"},"breadcrumb":{"@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/#primaryimage","url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/09\/EX-7014_ESC_EN_Fig_1.png","contentUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/09\/EX-7014_ESC_EN_Fig_1.png","width":960,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/themedicalxchange.com\/en\/2017\/09\/08\/cantos-trial-advances-inflammatory-hypothesis-of-coronary-artery-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/themedicalxchange.com\/en\/"},{"@type":"ListItem","position":2,"name":"CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease"}]},{"@type":"WebSite","@id":"https:\/\/themedicalxchange.com\/en\/#website","url":"https:\/\/themedicalxchange.com\/en\/","name":"The Medical Xchange","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/themedicalxchange.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/f3318b53ccceaeb046bcb26e99f5c94c","name":"Daniela Lopes","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g","caption":"Daniela Lopes"},"url":"https:\/\/themedicalxchange.com\/en\/author\/daniela\/"}]}},"_links":{"self":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/posts\/6932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/comments?post=6932"}],"version-history":[{"count":0,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/posts\/6932\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/media\/6955"}],"wp:attachment":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/media?parent=6932"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/tags?post=6932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}